Pediatric multiple sclerosis: a review
R Alroughani, A Boyko - BMC neurology, 2018 - Springer
Background Pediatric-onset multiple sclerosis (POMS) prevalence and incidence rates are
increasing globally. No disease-modifying therapy are approved for MS pediatric population …
increasing globally. No disease-modifying therapy are approved for MS pediatric population …
[HTML][HTML] Causes and risk factors of drug-resistant epilepsy in children
Objectives Epilepsy, the tendency to have recurrent unprovoked seizures, is the most
common chronic neurological disorder worldwide. About 20% to 40% of children with …
common chronic neurological disorder worldwide. About 20% to 40% of children with …
Pediatric multiple sclerosis and its familial recurrence: A population based study (1999–2017)
S Eskandarieh, MA Sahraiain, N Molazadeh… - Multiple sclerosis and …, 2019 - Elsevier
Abstract Background The Pediatric onset multiple sclerosis (POMS) prevalence is increasing
worldwide accounting for around 3 to 10% of MS cases. The risk of POMS is supposed to …
worldwide accounting for around 3 to 10% of MS cases. The risk of POMS is supposed to …
Characteristics of pediatric multiple sclerosis: A tertiary referral center study
Objective The present study represents one of the largest series of pediatric multiple
sclerosis (PedMS) in Western Balkan region. This is the first study aimed to evaluate the …
sclerosis (PedMS) in Western Balkan region. This is the first study aimed to evaluate the …
[HTML][HTML] Clinical and Epidemiological Findings of Pediatric Onset Multiple Sclerosis in East-Azerbaijan, Iran; A Population-based Study
Clinical and Epidemiological Findings of Pediatric Onset Multiple Sclerosis in East-Azerbaijan,
Iran; A Population-based Study - PMC Back to Top Skip to main content NIH NLM Logo …
Iran; A Population-based Study - PMC Back to Top Skip to main content NIH NLM Logo …
[HTML][HTML] Epidemiological and clinical features of pediatric-onset multiple sclerosis: A population-based study in Isfahan, Iran, between 1997-2020
M Etemadifar, AP Abhari, G Yadegarfar… - Current Journal of …, 2021 - ncbi.nlm.nih.gov
Background: Pediatric-onset multiple sclerosis (POMS) is an autoimmune demyelinating
disorder of the central nervous system (CNS), affecting individuals younger than 18 years of …
disorder of the central nervous system (CNS), affecting individuals younger than 18 years of …
[HTML][HTML] Clinical Profile and Outcome of Pediatric Demyelinating Disorders in Calabar, Nigeria: A Case Series
Background: Demyelinating disorders of the central nervous system (CNS) are rare
disorders characterized by inflammation and the selective destruction of CNS myelin. The …
disorders characterized by inflammation and the selective destruction of CNS myelin. The …
Mehanizmi uticaja kliničkih i parakliničkih parametara na nastanak onesposobljenosti i progresiju moždanog oštećenja u korelaciji sa primenjenim terapijskim …
BD Nikolić - 2021 - search.proquest.com
MEHANIZMI UTICAJA KLINIČKIH I PARAKLINIČKIH PARAMETARA NA NASTANAK
ONESPOSOBLJENOSTI I PROGRESIJU MOŽDANOG OŠTEĆENJA U KORE Page 1 …
ONESPOSOBLJENOSTI I PROGRESIJU MOŽDANOG OŠTEĆENJA U KORE Page 1 …
Acquired demyelinating syndrome: single center experience.
Objective: Acquired demyelinating syndromes are immune-mediated demyelinating
disorders of the central nervous system. Clinical spectrum includes acute disseminated …
disorders of the central nervous system. Clinical spectrum includes acute disseminated …
Edinsel Demiyelinizan Sendrom: ID Tek Merkez Deneyimi.
Amaç: Edinsel demiyelinizan sendromlar, santral sinir sisteminin immün aracılı
demiyelinizan bozukluğudur. Klinik spektrum; akut dissemine ensefalomiyelit, optik nörit …
demiyelinizan bozukluğudur. Klinik spektrum; akut dissemine ensefalomiyelit, optik nörit …